Bioatla Inc (BCAB) stock news · $5.9M cap
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
This BCAB news page leads with what Bioatla Inc filed — not a scraped headline mill.
No cached 8-K sentence for BCAB yet. We will not pad this page with generic market recap.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BCAB stock page; for the tape open the quote page.
BCAB stock news FAQ
What is BCAB's latest net income?
Latest cached Bioatla Inc (BCAB) net income was -$33.3M. Statements: https://lician.com/financials/bcab
What is BCAB's market cap?
Bioatla Inc (BCAB) market cap is $5.9M on the latest cached fundamentals snapshot.
What kind of company is BCAB?
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Where is BCAB stock news listed?
Cached stock news for Bioatla Inc (BCAB) is listed at https://lician.com/news/bcab. Filings: https://lician.com/sec/bcab
Not investment advice.